Latest / Wilmington News Today | 2 Min News | The Daily News Now!
Medicare GLP-1 Weight Loss Access | Wilmington News
Starting July 1, Medicare patients may soon access weight-loss GLP-1 drugs under a new 18-month pilot program called Medicare GLP-1 Bridge, offering just a $50 monthly copay. Eligible beneficiaries—those with a BMI of 30+ or lower BMI with specific conditions—can get drugs like Zepbound and Wegovy, but only if their doctor submits prior authorization. Around 3.8 million people could qualify, though those already using GLP-1s for diabetes or sleep apnea are excluded. The program doesn’t count toward annual spending caps, and coupons aren’t accepted. Coverage ends December 31, 2027, unless…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.